Invega (generic: paliperidone) is a prescription medication used to treat symptoms of schizophrenia and schizoaffective disorder. Invega belongs to a group of drugs called atypical antipsychotics. It may work by changing the activity of certain natural substances in the brain.
Invega is a prescription medication used in the treatment of schizoaffective disorder in adults and for the treatment of schizophrenia in adults and in adolescents aged 12 to 17.
This medication may be prescribed for other uses. Ask your doctor or pharmacist for more information.
Invega may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:
- extreme tiredness
- dry mouth
- increased saliva
- weight gain
- stomach pain
Some side effects can be serious. If you experience any of these, call your doctor immediately:
- muscle pain or stiffness
- fast, pounding, or irregular heartbeat
- unusual movements of your face or body that you cannot control
- slow or stiff movements
- painful erection of the penis that lasts for hours
Invega may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.
Some medicines may interact with Invega which may increase side effects, and increase or decrease the action of either drug. Your doctor may need to change the doses of your medicines or carefully monitor for side effects if you are taking medicines that interact with Invega.
Tell your doctor about the medicines you take including prescription and nonprescription medications, vitamins, nutritional supplements, and herbal supplements. Especially tell your doctor if you take:
- certain antibiotics such as erythromycin (E.E.S., E-Mycin, Erythrocin), moxifloxacin (Avelox), and sparfloxacin (Zagam)
- certain antipsychotics such as chlopromazine (Sonazine, Thorazine), pimozide (Orap), risperidone (Risperdal) and thioridazine
- cisapride (Propulsid)
- levodopa (in Sinemet, in Stalevo)
- medications for anxiety
- high blood pressure medicines
- medications for seizures
- medications for irregular heartbeat such as amiodarone (Cordarone), disopyramide (Norpace), dofetilide (Tikosyn); procainamide (Procanbid, Pronestyl), quinidine (Quinidex), and sotalol (Betapace, Betapace AF)
- sleeping pills
Invega has caused some rare, but serious side effects including Neuroleptic Malignant Syndrome (NMS), Tardive Dyskinesia (TD) and changes in heart rhythm. It has also been associated with high blood sugar and diabetes, changes in cholesterol and triglycerides, and weight gain. Invega and similar medicines have been associated with decreases in white blood cell counts.
Invega should be used with caution in people with a seizure disorder or those at increased risk for seizures.
Tell your doctor if you are allergic to Invega, risperidone (Risperdal) or any other medications.
Tell your doctor if you have heart problems. If you have or have ever had a rare heart problem that may cause fainting or irregular heartbeat (prolonged QT interval) or a heart attack, you should tell your doctor before taking Invega.
Tell your doctor if you have or have ever had any condition that causes blockage or narrowing of the esophagus, stomach, or intestines. Also tell your doctor if you have inflammatory bowel disease (IBD), and kidney or liver disease.
Tell your doctor if you are pregnant, planning to become pregnant or breastfeeding. Invega may harm your unborn baby or your nursing baby.
Invega may cause drowsiness. You should not drive a car or operate machinery until you know how it will affect you. You should not drink alcohol while on Invega. Alcohol may add to the drowsiness caused by Invega.
While taking Invega, you may experience increases in your blood sugar (hyperglycemia) even if you don't already have diabetes. You may be at an increased risk of developing diabetes if you take Invega or similar medicines.
Invega may make it harder for your body to cool down during exercise or in hot weather.
Get out of bed slowly, resting your feet on the floor before standing, to avoid dizziness, lightheadedness, and fainting while taking Invega.
Medicines can interact with certain foods. In some cases, this may be harmful and your doctor may advise you to avoid certain foods. In the case of Invega there are no specific foods that you must exclude from your diet when receiving Invega.
Tell your doctor and pharmacist if you are allergic to Invega (paliperidone), risperidone (Risperdal), or any other medications.
Tell your doctor about the medicines you take including prescription and nonprescription medications, vitamins, nutritional supplements, and herbal supplements. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
Tell your doctor if you have or have ever had a prolonged QT interval (a rare heart problem that may cause fainting or irregular heartbeat); slow or irregular heartbeat; a heart attack; low levels of potassium or magnesium in your blood; seizures; a stroke; a head injury; a brain tumor; Parkinson's disease (a disorder of the nervous system that causes difficulties with movement, muscle control, and balance); diabetes; breast cancer; surgery involving the intestines; any condition that causes blockage or narrowing of the esophagus (tube that connects the mouth and stomach), stomach, or intestines such as cystic fibrosis (an inborn disease that causes problems with breathing, digestion, and reproduction), and inflammatory bowel disease (IBD; a group of conditions that cause swelling of the lining of the intestines); and kidney, heart, or liver disease.
Tell your doctor if you are pregnant, or if you plan to become pregnant or are breastfeeding. If you become pregnant while taking Invega, call your doctor.
If you are having surgery, including dental surgery, tell the doctor or dentist that you are taking Invega.
Tell your doctor if you plan to exercise or be exposed to extreme heat.
Tell your doctor if you are pregnant or planning to become pregnant. It is not known if Invega will harm your unborn baby.
Tell your doctor if you are breastfeeding or plan to breastfeed. It is not known if Invega is excreted in human breast milk or if it will harm your nursing baby.
Invega is an extended-release (long-acting) tablet to take by mouth. It is usually taken once a day in the morning with or without food. Take it at around the same time every day. Do not take more or less of it or take it more often than prescribed by your doctor.
Swallow the tablets whole with plenty of water or other liquid. Do not split, chew, or crush the tablets.
Continue to take Invega even if you feel well. Do not stop taking Invega without talking to your doctor.
Take Invega exactly as prescribed by your doctor. Follow the directions on your prescription label carefully. Do not take more or less of it or take it more often than prescribed by your doctor. Continue to take Invega even if you feel well. Do not stop taking Invega without talking to your doctor.
The recommended dose of Invega Extended-Release Tablets for the treatment of schizophrenia in adults is 6 mg administered once daily. The maximum recommended dose is 12 mg a day.
The recommended starting dose of Invega Extended-Release Tablets for the treatment of schizophrenia in adolescents 12–17 years of age is 3 mg administered once daily. Dose increases may be required, and should occur at increments of 3 mg/day at intervals of more than 5 days.
The recommended dose of Invega Extended-Release Tablets for the treatment of schizoaffective disorder in adults is 6 mg administered once daily. The maximum recommended dose is 12 mg a day.
If you take too much Invega (more than the prescribed dose), call your local Poison Control Center or seek emergency medical attention right away.
Invega Extended-Release Tablets are available in the following strengths and colors: 1.5 mg (orange-brown), 3 mg (white), 6 mg (beige), and 9 mg (pink).
Store up to 25ºC (77ºF); excursions permitted to 15 – 30ºC (59 – 86ºF) Controlled Room Temperature. Protect from moisture.
Keep this and all medicines out of the reach of children.
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Analyses of 17 placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients. Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature. Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality. The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear. Invega (paliperidone) Extended-Release Tablets is not approved for the treatment of patients with dementia-related psychosis
Sign up for
- Follow the medications that matter most to you
- Receive email notifications as soon as your medication pages are updated